|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1995-5-12
|
|
pubmed:abstractText |
To determine whether individuals with concurrent active psychiatric disease and chronic hepatitis C virus (HCV) can be treated safely and effectively with interferon-alpha.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0954-691X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
7
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
165-8
|
|
pubmed:dateRevised |
2009-10-16
|
|
pubmed:meshHeading |
pubmed-meshheading:7712309-Adult,
pubmed-meshheading:7712309-Alanine Transaminase,
pubmed-meshheading:7712309-Chronic Disease,
pubmed-meshheading:7712309-Female,
pubmed-meshheading:7712309-Hepacivirus,
pubmed-meshheading:7712309-Hepatitis C,
pubmed-meshheading:7712309-Humans,
pubmed-meshheading:7712309-Interferon-alpha,
pubmed-meshheading:7712309-Male,
pubmed-meshheading:7712309-Mental Disorders,
pubmed-meshheading:7712309-Middle Aged,
pubmed-meshheading:7712309-Prospective Studies,
pubmed-meshheading:7712309-RNA, Viral
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Interferon-alpha can be used successfully in patients with hepatitis C virus-positive chronic hepatitis who have a psychiatric illness.
|
|
pubmed:affiliation |
Oklahoma Transplant Institute, Baptist Medical Center of Oklahoma, Oklahoma City 73112, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial
|
